This is a StreetInsider.com Premium Only Page

Aptevo Therapeutics (APVO) –

Apr 23, 2024 04:16 PM Form ARS Aptevo Therapeutics Inc. For: Dec 31

Apr 23, 2024 04:11 PM Form DEFA14A Aptevo Therapeutics Inc.

Apr 23, 2024 04:05 PM Form DEF 14A Aptevo Therapeutics Inc. For: Dec 31

Apr 15, 2024 04:17 PM Form 8-K Aptevo Therapeutics Inc. For: Apr 10

Apr 15, 2024 04:05 PM Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering

Apr 12, 2024 05:24 PM Form 424B4 Aptevo Therapeutics Inc.

Apr 11, 2024 08:05 AM Aptevo Therapeutics (APVO) Prices 3.4M Share Offering at $1.35/sh

Apr 11, 2024 08:00 AM Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

Apr 11, 2024 06:03 AM Form EFFECT Aptevo Therapeutics Inc.

Apr 10, 2024 09:04 AM Aptevo Therapeutics (APVO) Provides Pipeline Update

Apr 10, 2024 09:00 AM Aptevo Therapeutics Provides Pipeline Update

Apr 9, 2024 05:26 PM Form S-1/A Aptevo Therapeutics Inc.

Mar 29, 2024 05:01 PM Form S-1/A Aptevo Therapeutics Inc.

Mar 20, 2024 04:16 PM Form S-1 Aptevo Therapeutics Inc.

Mar 18, 2024 06:00 AM Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference

Mar 7, 2024 08:57 AM Form 8-K Aptevo Therapeutics Inc. For: Mar 07

Mar 7, 2024 08:56 AM Aptevo Therapeutics (APVO) and Alligator Bioscience Report Positive Interim Data of Dose Escalation Phase of ALG.APV-527

Mar 7, 2024 08:55 AM Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4

Mar 5, 2024 05:05 PM Form 8-K Aptevo Therapeutics Inc. For: Mar 05

Mar 5, 2024 04:14 PM Form 4 Aptevo Therapeutics Inc. For: Mar 02 Filed by: Taylor Daphne

Mar 5, 2024 04:12 PM Form 4 Aptevo Therapeutics Inc. For: Mar 02 Filed by: Lamothe Jeffrey G.

Mar 5, 2024 04:08 PM Form 4 Aptevo Therapeutics Inc. For: Mar 02 Filed by: Kwon SoYoung

Mar 5, 2024 04:07 PM Form 4 Aptevo Therapeutics Inc. For: Mar 02 Filed by: White Marvin L

Mar 5, 2024 08:31 AM Form 10-K Aptevo Therapeutics Inc. For: Dec 31

Mar 5, 2024 08:15 AM Form 8-K Aptevo Therapeutics Inc. For: Mar 05

Mar 5, 2024 08:05 AM Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update

Mar 4, 2024 09:04 AM Aptevo Therapeutics (APVO) Announces 1:44 Reverse Share Split

Mar 4, 2024 09:00 AM Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan

Feb 14, 2024 03:24 PM Form SC 13G Aptevo Therapeutics Inc. Filed by: ARMISTICE CAPITAL, LLC

Feb 6, 2024 04:37 PM Form 8-K Aptevo Therapeutics Inc. For: Feb 05

Jan 30, 2024 06:06 PM Form 4 Aptevo Therapeutics Inc. For: Jan 29 Filed by: Taylor Daphne

Jan 30, 2024 06:05 PM Form 4 Aptevo Therapeutics Inc. For: Jan 28 Filed by: Lamothe Jeffrey G.

Jan 30, 2024 06:03 PM Form 4 Aptevo Therapeutics Inc. For: Jan 28 Filed by: White Marvin L

Jan 30, 2024 08:00 AM Form DEFR14A Aptevo Therapeutics Inc.

Jan 16, 2024 04:15 PM Form DEFR14A Aptevo Therapeutics Inc.

Dec 22, 2023 04:15 PM Form DEF 14A Aptevo Therapeutics Inc. For: Dec 22

Dec 12, 2023 04:19 PM Form PRE 14A Aptevo Therapeutics Inc. For: Dec 13

Dec 1, 2023 06:05 AM Form EFFECT Aptevo Therapeutics Inc.

Nov 22, 2023 04:08 PM Aptevo Therapeutics (APVO) Announces 32.03M Share Offering by Selling Stockholders

Nov 22, 2023 04:06 PM Form S-3 Aptevo Therapeutics Inc.

Nov 14, 2023 08:31 AM Form 10-Q Aptevo Therapeutics Inc. For: Sep 30

Nov 14, 2023 08:17 AM Form 8-K Aptevo Therapeutics Inc. For: Nov 14

Nov 14, 2023 08:05 AM Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update

Nov 9, 2023 05:18 PM Form 8-K Aptevo Therapeutics Inc. For: Nov 09

Nov 3, 2023 04:15 PM Form 8-K Aptevo Therapeutics Inc. For: Nov 02

Nov 1, 2023 07:45 AM Aptevo to Present at Bio-Europe Conference

Oct 9, 2023 07:08 AM Alliance Global Partners Starts Aptevo Therapeutics (APVO) at Buy

Sep 15, 2023 04:30 PM Form 8-K Aptevo Therapeutics Inc. For: Sep 13

Aug 10, 2023 04:13 PM Form 4 Aptevo Therapeutics Inc. For: Aug 09 Filed by: Niederhuber John

Aug 10, 2023 04:10 PM Form 4 Aptevo Therapeutics Inc. For: Aug 09 Filed by: Kunz Barbara Lopez